Related Experiment Video
Updated: Mar 19, 2026

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
Published on: September 14, 2013
Characteristics of the Clostridium difficile cell envelope and its importance in therapeutics
Joseph A Kirk1, Oishik Banerji1, Robert P Fagan1
1Krebs Institute, Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, S10 2TN, UK.
Abstract:
Clostridium difficile infection (CDI) is a challenging threat to human health. Infections occur after disruption of the normal microbiota, most commonly through the use of antibiotics. Current treatment for CDI largely relies on the broad-spectrum antibiotics vancomycin and metronidazole that further disrupt the microbiota resulting in frequent recurrence, highlighting the need for C. difficile-specific antimicrobials. The cell surface of C. difficile represents a promising target for the development of new drugs. C. difficile possesses a highly deacetylated peptidoglycan cell wall containing unique secondary cell wall polymers. Bound to the cell wall is an essential S-layer, formed of SlpA and decorated with an additional 28 related proteins. In addition to the S-layer, many other cell surface proteins have been identified, including several with roles in host colonization. This review aims to summarize our current understanding of these different C. difficile cell surface components and their viability as therapeutic targets.
Insights
Clostridium difficile infection (CDI) treatments disrupt the gut microbiota, leading to recurrence. Targeting C. difficile cell surface components offers a promising strategy for developing new, specific antimicrobials to combat this infection.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Clostridium difficile infection (CDI) is a significant health concern, often recurring due to current antibiotic treatments that disrupt the gut microbiota.
- Existing treatments like vancomycin and metronidazole are broad-spectrum, exacerbating microbiota disruption and leading to high CDI recurrence rates.
Purpose of the Study:
- To review the cell surface components of Clostridium difficile as potential targets for novel antimicrobial therapies.
- To explore the viability of C. difficile-specific antimicrobials to overcome treatment limitations.
Main Methods:
- Literature review of studies on Clostridium difficile cell surface structures.
- Analysis of the role of peptidoglycan, secondary cell wall polymers, and the S-layer in C. difficile biology.
- Identification of cell surface proteins involved in host colonization.
Main Results:
- The C. difficile cell surface, including its unique peptidoglycan and S-layer (SlpA and associated proteins), presents a promising target.
- Numerous other cell surface proteins have been identified with roles in C. difficile pathogenesis and colonization.
- These components offer potential for developing targeted therapies.
Conclusions:
- The cell surface of Clostridium difficile is a rich source of potential therapeutic targets for developing new drugs.
- Targeting these specific components could lead to more effective treatments with reduced microbiota disruption and lower recurrence rates.
More Related Videos
Related Concept Videos
Bacterial Cell Wall
Outer Layers of the Cell Envelope
Endospores and Sporulation
Bacterial Toxins
Inhibitors of Gram-positive Cell Wall Synthesis
Colonisation of Pathogens

